170 related articles for article (PubMed ID: 28214281)
1. Patient characterization and usage trends of proton beam therapy for localized prostate cancer in the United States: A study of the National Cancer Database.
Amini A; Raben D; Crawford ED; Flaig TW; Kessler ER; Lam ET; Maroni P; Pugh TJ
Urol Oncol; 2017 Jun; 35(6):438-446. PubMed ID: 28214281
[TBL] [Abstract][Full Text] [Related]
2. Overall Survival After Treatment of Localized Prostate Cancer With Proton Beam Therapy, External-Beam Photon Therapy, or Brachytherapy.
Liu Y; Patel SA; Jani AB; Gillespie TW; Patel PR; Godette KD; Hershatter BW; Shelton JW; McDonald MW
Clin Genitourin Cancer; 2021 Jun; 19(3):255-266.e7. PubMed ID: 32972877
[TBL] [Abstract][Full Text] [Related]
3. Implementation of hypofractionated prostate radiation therapy in the United States: A National Cancer Database analysis.
Stokes WA; Kavanagh BD; Raben D; Pugh TJ
Pract Radiat Oncol; 2017; 7(4):270-278. PubMed ID: 28673554
[TBL] [Abstract][Full Text] [Related]
4. Prostate brachytherapy, either alone or in combination with external beam radiation, is associated with longer overall survival in men with favorable pathologic Group 4 (Gleason score 8) prostate cancer.
Jackson MW; Amini A; Jones BL; Kavanagh B; Maroni P; Frank SJ; Mahmood U; Kudchadker RJ; Pugh TJ
Brachytherapy; 2017; 16(4):790-796. PubMed ID: 28442277
[TBL] [Abstract][Full Text] [Related]
5. Differences in Patterns of Care and Referral Between Proton and Photon Therapy.
Hasan S; Verma V; Abel S; Wegner RE; Choi JI; Press RH; Chhabra A; Simone CB
Int J Part Ther; 2024 Mar; 11():100005. PubMed ID: 38757072
[TBL] [Abstract][Full Text] [Related]
6. Association Between Travel Distance and Choice of Treatment for Prostate Cancer: Does Geography Reduce Patient Choice?
Muralidhar V; Rose BS; Chen YW; Nezolosky MD; Nguyen PL
Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):313-317. PubMed ID: 27496390
[TBL] [Abstract][Full Text] [Related]
7. Association of Race With Receipt of Proton Beam Therapy for Patients With Newly Diagnosed Cancer in the US, 2004-2018.
Nogueira LM; Sineshaw HM; Jemal A; Pollack CE; Efstathiou JA; Yabroff KR
JAMA Netw Open; 2022 Apr; 5(4):e228970. PubMed ID: 35471569
[TBL] [Abstract][Full Text] [Related]
8. Patterns of Care in Proton Radiation Therapy for Pediatric Central Nervous System Malignancies.
Odei B; Frandsen JE; Boothe D; Ermoian RP; Poppe MM
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):60-63. PubMed ID: 27816365
[TBL] [Abstract][Full Text] [Related]
9. Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of Care survey for prostate cancer.
Zelefsky MJ; Moughan J; Owen J; Zietman AL; Roach M; Hanks GE
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1053-61. PubMed ID: 15234039
[TBL] [Abstract][Full Text] [Related]
10. Differential Use of Radiotherapy Fractionation Regimens in Prostate Cancer.
Qureshy SA; Diven MA; Ma X; Marciscano AE; Hu JC; McClure TD; Barbieri C; Nagar H
JAMA Netw Open; 2023 Oct; 6(10):e2337165. PubMed ID: 37815829
[TBL] [Abstract][Full Text] [Related]
11. Lack of Benefit From the Addition of External Beam Radiation Therapy to Brachytherapy for Intermediate- and High-risk Prostate Cancer.
Yang DD; Muralidhar V; Nguyen PL; Buzurovic I; Martin NE; Mouw KW; Devlin PM; Trinh QD; Orio PF; King MT
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):904-911. PubMed ID: 29063853
[TBL] [Abstract][Full Text] [Related]
12. The impact of brachytherapy on prostate cancer-specific mortality for definitive radiation therapy of high-grade prostate cancer: a population-based analysis.
Shen X; Keith SW; Mishra MV; Dicker AP; Showalter TN
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1154-9. PubMed ID: 22270175
[TBL] [Abstract][Full Text] [Related]
13. Gleason stratifications prognostic for survival in men receiving definitive external beam radiation therapy for localized prostate cancer.
Rusthoven CG; Waxweiler TV; DeWitt PE; Flaig TW; Raben D; Kavanagh BD
Urol Oncol; 2015 Feb; 33(2):71.e11-9. PubMed ID: 25151595
[TBL] [Abstract][Full Text] [Related]
14. Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis.
Smith GD; Pickles T; Crook J; Martin AG; Vigneault E; Cury FL; Morris J; Catton C; Lukka H; Warner A; Yang Y; Rodrigues G
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):505-16. PubMed ID: 25596107
[TBL] [Abstract][Full Text] [Related]
15. Lack of Apparent Survival Benefit With Use of Androgen Deprivation Therapy in Patients With High-risk Prostate Cancer Receiving Combined External Beam Radiation Therapy and Brachytherapy.
Yang DD; Muralidhar V; Mahal BA; Nguyen PL; Devlin PM; King MT; Orio PF
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):53-58. PubMed ID: 29254781
[TBL] [Abstract][Full Text] [Related]
16. A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer.
Fang P; Mick R; Deville C; Both S; Bekelman JE; Christodouleas JP; Guzzo TJ; Tochner Z; Hahn SM; Vapiwala N
Cancer; 2015 Apr; 121(7):1118-27. PubMed ID: 25423899
[TBL] [Abstract][Full Text] [Related]
17. National trends and determinants of proton therapy use for prostate cancer: A National Cancer Data Base study.
Mahal BA; Chen YW; Efstathiou JA; Muralidhar V; Hoffman KE; Yu JB; Feng FY; Beard CJ; Martin NE; Orio PF; Nguyen PL
Cancer; 2016 May; 122(10):1505-12. PubMed ID: 26970022
[TBL] [Abstract][Full Text] [Related]
18. Proton therapy expansion under current United States reimbursement models.
Kerstiens J; Johnstone PA
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):235-40. PubMed ID: 24685152
[TBL] [Abstract][Full Text] [Related]
19. External beam radiation treatment for rectal cancer is associated with a decrease in subsequent prostate cancer diagnosis.
Hoffman KE; Hong TS; Zietman AL; Russell AH
Cancer; 2008 Feb; 112(4):943-9. PubMed ID: 18098220
[TBL] [Abstract][Full Text] [Related]
20. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
